Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001356576-24-000051
Filing Date
2024-08-06
Accepted
2024-08-06 16:18:50
Documents
87
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q supn-20240630.htm   iXBRL 10-Q 1112689
2 EX-10.1 ex101-settlementagreementb.htm EX-10.1 388477
3 EX-31.1 supn-20240630x10qxex311.htm EX-31.1 9655
4 EX-31.2 supn-20240630x10qxex312.htm EX-31.2 10017
5 EX-32.1 supn-20240630x10qxex321.htm EX-32.1 5143
6 EX-32.2 supn-20240630x10qxex322.htm EX-32.2 5160
12 GRAPHIC supn-20240630_g1.jpg GRAPHIC 90482
  Complete submission text file 0001356576-24-000051.txt   7242177

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT supn-20240630.xsd EX-101.SCH 44270
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT supn-20240630_cal.xml EX-101.CAL 79094
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT supn-20240630_def.xml EX-101.DEF 184984
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT supn-20240630_lab.xml EX-101.LAB 603862
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT supn-20240630_pre.xml EX-101.PRE 410450
89 EXTRACTED XBRL INSTANCE DOCUMENT supn-20240630_htm.xml XML 988016
Mailing Address 9715 KEY WEST AVENUE ROCKVILLE MD 20850
Business Address 9715 KEY WEST AVENUE ROCKVILLE MD 20850 301-838-2500
SUPERNUS PHARMACEUTICALS, INC. (Filer) CIK: 0001356576 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35518 | Film No.: 241179562
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)